Vertex to Present at the Morgan Stanley Global Healthcare Conference on September 10
03 September 2014 - 6:01AM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that it will present at the Morgan Stanley Global
Healthcare Conference on Wednesday, September 10 at 8:35 a.m.
ET.
Management’s remarks can be accessed live through Vertex’s
website at www.vrtx.com in the “Investors” section under the
“Events and Presentations” link. To ensure a timely connection, it
is recommended that users register at least 10 minutes prior to the
scheduled webcast. A replay of the webcast will also be archived on
the company’s website for a period of two weeks following the
presentation.
About Vertex
Vertex is a global biotechnology company that aims to discover,
develop and commercialize innovative medicines so people with
serious diseases can lead better lives. In addition to our clinical
development programs focused on cystic fibrosis, Vertex has more
than a dozen ongoing research programs aimed at other serious and
life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research
and development sites and commercial offices in the United States,
Europe, Canada and Australia. For four years in a row, Science
magazine has named Vertex one of its Top Employers in the life
sciences. For additional information and the latest updates from
the company, please visit www.vrtx.com.
(VRTX-WEB)
Source: Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals
IncorporatedInvestors:Michael Partridge,
617-341-6108orKelly Lewis, 617-961-7530
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2024 to May 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From May 2023 to May 2024